one cancer patient that is put into remission with VitC. Using other therapies like menadione is another therapy by itself. Monotherapy with VitC and remmission so far doesn't exist. G6PD deficiency is risk by itself before you give VitC. This is another risk factor. If not checked you woould kill the patient by massive haemolysis.
-Chakra.
--- On Thu, 7/8/08, VGammill wrote:
Another miserable study published in a journal that is not about to
publish anything that praises ascorbate. With this kind of approach
you can easily make any therapy look bad. What is the purpose of
this investigation? Getting published? More grant money?
If you want to know the truth you take a completely different
approach. You go to those who are getting good results with
ascorbate, you hang around and watch what they do, see how they
screen their patients, note what other drugs and supplements are used
(or avoided), and ask them their opinions of why others fail. How
many researchers add menadione, subtract B-6, monitor G6PD/hemolysis?
Fresh asparagus is very high in ascorbate: 2,500 calories can contain
as much as 12 grams. Seven years ago I got a call from an elderly
woman with non-small cell lung cancer. She had no money for the
usual meds. I told her to eat plenty of asparagus with every meal
even if it came from a can. What would she be afraid of -- getting
cancer 30 years from now? The woman is still alive with no evidence
of cancer.
Vincent
------------------------------------
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/cancercured/
<*> Your email settings:
Individual Email | Traditional
<*> To change settings online go to:
http://groups.yahoo.com/group/cancercured/join
(Yahoo! ID required)
<*> To change settings via email:
mailto:cancercured-digest@yahoogroups.com
mailto:cancercured-fullfeatured@yahoogroups.com
<*> To unsubscribe from this group, send an email to:
cancercured-unsubscribe@yahoogroups.com
<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/
Tidak ada komentar:
Posting Komentar